IMMU-03. THERAPEUTIC TARGETING OF TUMORIGENIC
EphA2+/EphA3+ BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA

Human glioblastoma (hGBM) carries a dismal prognosis and inevitably relapses despite aggressive therapy. Many of the 14 members of the Eph receptor tyrosine kinase family are expressed in hGBM initiating cells (GICs) and constitute potential molecular targets. We hypothesize that multiple members of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Qazi, Maleeha, Vora, Parvez, Venugopal, Chitra, Gorelik, Maryna, Singh, Mohini, Hu, Amy, Subapanditha, Minomi, Chokshi, Chirayu, Savage, Neil, Yelle, Nicholas, Adams, Jarrett, Moffat, Jason, Sidhu, Sachdev, Singh, Sheila
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692371/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.462
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items